Skip to content

Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer

Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06017271
Enrollment
0
Registered
2023-08-30
Start date
2024-05-01
Completion date
2024-07-19
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Pulmonary Embolism

Brief summary

The occurrence and progression of lung cancer is related to visceral adipose tissue (VAT). Epicardial adipose tissue (EAT) is a kind of VAT, producing a variety of inflammatory cytokines and adipokines, participating in the formation of local inflammation, promoting the formation of pre-thrombotic state, and leading to the occurrence of thromboembolism. Patients with lung cancer have increased inflammatory response and are more prone to suffer thrombosis. However, in lung cancer patients, the clinical correlation between EAT and pulmonary embolism has not been reported. Objective: To analyze the risk factors of poor prognosis in lung cancer patients with PE, and to explore the predictive value of EAT in pulmonary embolism events and death in lung cancer patients. Methods: EAT volume and density, as well as anthropometric and blood biomarkers, were evaluated in a sample of lung cancer patients, half with pulmonary embolism and half without. The incidence of adverse prognosis and related factors were followed up by telephone.

Interventions

DIAGNOSTIC_TESTCTPA (computed tomography pulmonary angiography)

The CTPA diagnosis suggest or did not suggest pulmonary embolism.

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* The pathological diagnosis was lung cancer * Pulmonary artery was evaluated by CTA during hospitalization.

Exclusion criteria

* Patients with incomplete clinical data * Patients with no follow-up data * Patients with a history of PE before diagnosis of lung cancer

Design outcomes

Primary

MeasureTime frameDescription
EAT volumeMay, 20, 2023volume of epicardial adipose tissue (EAT), Cm3
EAT densityMay, 20, 2023density of epicardial adipose tissue (EAT) , Hounsfield Units (HU)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026